Details of the Drug

General Information of Drug (ID: DMNXAUZ)

Drug Name

1-hydroxyl-3,5-bis(4-hydroxylstyryl)benzene derivative 3

Synonyms

PMID25553724-Compound-US2014000527529

Indication

Disease Entry	ICD 11	Status	REF
Muscular wasting	8C7Y	Patented	[1]
Skin disease	EA00-EM0Z	Patented	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D Structure is Not Available

3D MOL

2D MOL

Cross-matching ID

Repurposed Drugs (RPD)

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Nuclear factor NF-kappa-B (NFKB)	TTSXVID	NFKB1_HUMAN ; NFKB2_HUMAN ; TF65_HUMAN ; RELB_HUMAN ; REL_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	Novel NF-B inhibitors: a patent review (2011 - 2014).Expert Opin Ther Pat. 2015 Mar;25(3):319-34.